Error: Could not add to watchlist. X

Supernus Pharmaceuticals Inc

+ Watchlist
SUPN:US
NASDAQ GM
19.64
USD
0.11
0.56%
As of 13:49:07 ET on 09/03/2015.
Open
19.96
Day Range
19.17 - 20.46
Volume
565,463
Previous Close
19.75
52Wk Range
7.31 - 23.30
1 Yr Return
124.14%
Open
19.96
Day Range
19.17 - 20.46
Volume
565,463
Previous Close
19.75
52Wk Range
7.31 - 23.30
1 Yr Return
124.14%
YTD Return
136.02%
Current P/E Ratio (TTM)
24.03
Earnings per Share (USD) (TTM)
0.83
Market Cap (m USD)
966.503
Shares Outstanding (m)
48.446
Price/Sales (TTM)
5.93
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
ADDRESS
1550 East Gude Drive
Rockville, MD 20850
United States
PHONE
1-301-838-2500
  • Jack A Khattar
    President/CEO/Secy/Founder
  • Stefan K F Schwabe
    Exec VP:Rsch & Dev
  • Padmanabh P Bhatt
    Senior VP:Intellectual Property
  • Victor L Vaughn
    Senior VP:Sales & Mktg
  • Gregory S Patrick
    VP/CFO/Investor Relations
Show More